Thirty-two mutations were detected in 15 patients with de novo BCR::ABL1+ AML whereas 21 mutations were detected in 19 CML-BP patients. The gene discussed is ABL1; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.